HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven R Smith Selected Research

lorcaserin

1/2019Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.
11/2018Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.
1/2018Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial.
1/2018Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
1/2017Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study.
10/2014Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes.
7/2013Echocardiographic assessment of cardiac valvular regurgitation with lorcaserin from analysis of 3 phase 3 clinical trials.
7/2012Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study.
10/2011A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.
3/2011Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven R Smith Research Topics

Disease

48Insulin Resistance
11/2019 - 06/2002
45Weight Loss (Weight Reduction)
01/2022 - 07/2004
39Obesity
09/2021 - 09/2002
32Overweight
01/2022 - 11/2002
24Type 2 Diabetes Mellitus (MODY)
11/2019 - 12/2003
24Body Weight (Weight, Body)
06/2019 - 11/2002
14Inflammation (Inflammations)
06/2020 - 09/2002
9Weight Gain
12/2020 - 01/2005
5Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2020 - 10/2004
5Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 11/2002
4Abdominal Obesity
01/2022 - 11/2007
3Myocardial Infarction
01/2019 - 03/2016
3Heart Failure
01/2018 - 12/2004
3Hyperinsulinism (Hyperinsulinemia)
08/2016 - 03/2010
3Nausea
10/2011 - 09/2009
3Hypoxia (Hypoxemia)
08/2010 - 02/2006
3Bone Resorption
12/2008 - 04/2003
2Hyperphagia (Overeating)
12/2020 - 01/2012
2Metabolic Diseases (Metabolic Disease)
01/2020 - 01/2018
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2018 - 01/2018
2Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 07/2012
2Stroke (Strokes)
01/2018 - 03/2016
2Diabetes Mellitus
07/2012 - 09/2010
2Dizziness (Lightheadedness)
10/2011 - 07/2010
2Headache (Headaches)
10/2011 - 07/2010
2Hypoadiponectinemia
02/2008 - 11/2007
2Atherosclerosis
07/2006 - 01/2006
2Sleep Deprivation
08/2003 - 08/2003

Drug/Important Bio-Agent (IBA)

30LipidsIBA
01/2022 - 06/2002
25Insulin (Novolin)FDA Link
01/2019 - 11/2002
21Glucose (Dextrose)FDA LinkGeneric
06/2020 - 11/2002
13Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2009
12lorcaserinIBA
01/2019 - 03/2009
11CarbohydratesIBA
01/2022 - 07/2005
8Nonesterified Fatty Acids (NEFA)IBA
12/2020 - 01/2005
8Triglycerides (Triacylglycerol)IBA
06/2011 - 01/2005
7Pioglitazone (Actos)FDA Link
04/2017 - 07/2004
7Messenger RNA (mRNA)IBA
01/2016 - 12/2003
7AdiponectinIBA
01/2013 - 06/2006
65-HT2C Serotonin ReceptorIBA
01/2019 - 07/2010
6Fatty Acids (Saturated Fatty Acids)IBA
05/2007 - 08/2002
4Dietary Fats (Dietary Fat)IBA
12/2020 - 09/2002
4LeptinIBA
10/2013 - 11/2007
4C-Reactive ProteinIBA
04/2013 - 06/2006
4Caffeine (No Doz)FDA LinkGeneric
05/2007 - 08/2003
3Biomarkers (Surrogate Marker)IBA
06/2021 - 04/2006
3HDL LipoproteinsIBA
12/2020 - 01/2006
3HDL CholesterolIBA
12/2020 - 06/2008
3CreatinineIBA
01/2019 - 04/2003
3Phentermine (Adipex-P)FDA LinkGeneric
01/2017 - 08/2003
3Pharmaceutical PreparationsIBA
08/2014 - 09/2009
3PPAR gammaIBA
01/2009 - 09/2006
3ThiazolidinedionesIBA
05/2007 - 07/2004
2FatsIBA
01/2022 - 09/2002
2Glucagon (Glukagon)FDA Link
09/2021 - 01/2021
2Indicators and Reagents (Reagents)IBA
01/2021 - 10/2018
2Dietary ProteinsIBA
12/2020 - 01/2012
2fibroblast growth factor 21IBA
01/2020 - 11/2016
2MyokinesIBA
01/2020 - 03/2016
2Amino AcidsFDA Link
01/2018 - 08/2003
2omega-Chloroacetophenone (Mace)IBA
01/2018 - 03/2016
2Adenosine Triphosphate (ATP)IBA
04/2017 - 12/2016
2Naltrexone (ReVia)FDA LinkGeneric
03/2016 - 04/2011
2Interleukin-6 (Interleukin 6)IBA
03/2016 - 06/2008
2AdipokinesIBA
01/2016 - 02/2015
2Growth Hormone (Somatotropin)IBA
02/2015 - 11/2007
2CeramidesIBA
02/2014 - 09/2009
2DiglyceridesIBA
06/2011 - 09/2009
2Anti-Obesity Agents (Antiobesity Drugs)IBA
06/2011 - 06/2011
2Lipase (Acid Lipase)FDA Link
06/2011 - 09/2009
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2010 - 03/2009
2Oxygen (Dioxygen)IBA
08/2010 - 03/2009
2Islet Amyloid PolypeptideIBA
09/2009 - 08/2007
2pramlintide (Symlin)FDA Link
09/2009 - 08/2007
2deoxypyridinolineIBA
12/2008 - 04/2003
2Triiodothyronine (Liothyronine)FDA LinkGeneric
12/2008 - 03/2004
2Angiotensin Receptor AntagonistsIBA
10/2008 - 12/2004
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2008 - 12/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2008 - 09/2006
2Alkaline PhosphataseIBA
06/2008 - 04/2003
2PPAR alphaIBA
01/2008 - 01/2006
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2006 - 01/2006
2CholesterolIBA
06/2006 - 01/2006
2Trans Fatty AcidsIBA
12/2005 - 09/2002
2Dextroamphetamine (Dexedrine)FDA LinkGeneric
08/2003 - 08/2003
2Tyrosine (L-Tyrosine)FDA Link
08/2003 - 08/2003
1AntigensIBA
09/2022
1AntiemeticsIBA
09/2022

Therapy/Procedure

11Caloric Restriction
01/2021 - 04/2006
10Therapeutics
06/2021 - 01/2005
7Glycemic Control
11/2019 - 01/2011
4Reducing Diet
01/2022 - 08/2011
4Fat-Restricted Diet (Diet, Fat Restricted)
06/2019 - 08/2011
3Protein-Restricted Diet (Diet, Protein Restricted)
12/2020 - 01/2012
3High-Protein Diet
12/2020 - 01/2012
3Bariatric Surgery
11/2015 - 06/2011
2Ketogenic Diet
01/2019 - 08/2016
2Electrodes (Electrode)
08/2010 - 03/2009
2Drug Therapy (Chemotherapy)
09/2009 - 12/2004
2Bed Rest (Bedrest)
12/2008 - 03/2004